Therapy
Research And Development
Health
Sangamo Therapeutics
$11.719876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$11.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.11 (0.95%) As of 10:53 AM EDT today
+$0.11 (0.95%) Today
Why Robinhood?
You can buy or sell SGMO and other stocks, options, ETFs, and crypto commission-free!
About SGMO
Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. Read More The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
Employees
302
Headquarters
Richmond, California
Founded
1995
Market Cap
1.19B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
3.71M
High Today
$11.87
Low Today
$11.61
Open Price
$11.70
Volume
403.72K
52 Week High
$19.25
52 Week Low
$6.26
Collections
Therapy
Research And Development
Health
Biotechnology
Engineering
Technology
SGMO News
Price Paid on Robinhood
15% Lower
Right Now
52 Week Low
$6.26
Average Price Paid
$13.74
52 Week High
$19.25
Analyst Ratings
63%
of 8 ratings
Buy
63%
Hold
38%
Sell
0%
SGMO Earnings
-$0.41
-$0.11
$0.18
$0.48
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 7, After Hours